|
LOC647859 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.311030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.872010E-01 |
| Normal-vs-Stage2 |
4.669400E-01 |
| Normal-vs-Stage3 |
2.353000E-01 |
| Normal-vs-Stage4 |
1.409990E-01 |
| Stage1-vs-Stage2 |
6.170000E-01 |
| Stage1-vs-Stage3 |
8.925200E-01 |
| Stage1-vs-Stage4 |
6.091600E-01 |
| Stage2-vs-Stage3 |
6.776800E-01 |
| Stage2-vs-Stage4 |
4.132400E-01 |
| Stage3-vs-Stage4 |
5.364600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.356200E-01 |
| Normal-vs-AfricanAmerican |
7.147600E-01 |
| Normal-vs-Asian |
1.419380E-01 |
| Caucasian-vs-AfricanAmerican |
6.864200E-01 |
| Caucasian-vs-Asian |
5.580200E-01 |
| AfricanAmerican-vs-Asian |
5.472800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.201600E-01 |
| Normal-vs-Female |
9.321900E-02 |
| Male-vs-Female |
2.746000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.953000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.069400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.645700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.348010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.801000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.977000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.923400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.000600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.626200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.532200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.109410E-01 |
| Classical-VS-Follicular |
2.054500E-02 |
| Classical-VS-Other |
4.99139999998732E-06 |
| Classical-VS-Normal |
3.404800E-01 |
| Tall-VS-Follicular |
8.635800E-01 |
| Tall-VS-Other |
6.285500E-02 |
| Tall-VS-Normal |
6.742200E-02 |
| Follicular-VS-Other |
1.102670E-03 |
| Follicular-VS-Normal |
4.169800E-02 |
| Other-VS-Normal |
4.479400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.660800E-01 |
| Normal-vs-N1 |
2.789500E-02 |
| N0-vs-N1 |
2.296200E-02 |
|
|
